The IKK-NF-κB pathway: A source for novel molecular drug targets in pain therapy?

FASEB Journal

Volumn 22, Issue 10, 2008, Pages 3432-3442

  Niederberger, Ellen ^a   Geisslinger, Gerd ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Inflammation; Nervous system; Neuropathy

Indexed keywords

1 [5 HYDROXY 2 (2 THIENYL) 4 QUINAZOLINYLAMINO] 3 METHYL 2,5 PYRROLEDIONE; 4 (2 AMINOETHYLAMINO) 1,8 DIMETHYLIMIDAZO[1,2 A]QUINOXALINE; ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; BETAMETHASONE; BORTEZOMIB; CELECOXIB; DEXAMETHASONE; ETORICOXIB; FLURBIPROFEN; GLUCOCORTICOID; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUMIRACOXIB; NEMO BINDING DOMAIN INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEASOME INHIBITOR; PYRROLIDINE DITHIOCARBAMATE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ROFECOXIB; S 1627; SALICYLATE SODIUM; SMALL INTERFERING RNA; SN 50; TACROLIMUS; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; ANALGESIC AGENT; I KAPPA B KINASE;

ALLODYNIA; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTHRITIS; DIGESTIVE SYSTEM ULCER; DRUG MECHANISM; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; MULTIPLE MYELOMA; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MOUSE; NERVOUS SYSTEM; PAIN;

ANIMALIA;

ANALGESICS; ANIMALS; HUMANS; I-KAPPA B KINASE; MICE; NERVOUS SYSTEM; NF-KAPPA B; PAIN;

EID: 54049114674     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.08-109355     Document Type: Review

References (120)

1. Karin, M., Yamamoto, Y., and Wang, Q. M. (2004) The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3, 17-26
2. Yamamoto, Y., and Gaynor, R. B. (2004) IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem. Sci. 29, 72-79
3. Hacker, H., and Karin, M. (2006) Regulation and function of IKK and IKK-related kinases. Sci. STKE 357, re13
4. Viatour, P., Merville, M. P., Bours, V., and Chariot, A. (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30, 43-52
5. Peters, R. T., and Maniatis, T. (2001) A new family of IKK-related kinases may function as I kappa B kinase kinases. Biochim. Biophys. Acta 1471, M57-62
6. Shimada, T., Kawai, T., Takeda, K., Matsumoto, M., Inoue, J., Tatsumi, Y., Kanamaru, A., and Akira, S. (1999) IKK-i, a novel lipopolysaccharide- inducible kinase that is related to IkappaB kinases. Int. Immunol. 11, 1357-1362
7. Sharma, S., tenOever, B. R., Grandvaux, N., Zhou, G. P., Lin, R., and Hiscott, J. (2003) Triggering the interferon antiviral response through an IKK-related pathway. Science 300, 1148-1151
8. McWhirter, S. M., Fitzgerald, K. A., Rosains, J., Rowe, D. C., Golenbock, D. T., and Maniatis, T. (2004) IFN-regulatory factor 3-dependent gene expression is defective in TBK1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 101, 233-238
9. Buss, H., Dorrie, A., Schmitz, M. L., Hoffmann, E., Resch, K., and Kracht, M. (2004) Constitutive and interleukin-1-inducible phosphorylation of p65 NF-κB at serine 536 is mediated by multiple protein kinases including IκB kinase (IKK)-α, IKKβ, IKKε, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 279, 55633-55643
10. Adli, M., and Baldwin, A. S. (2006) IKK-i/IKKe controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation. J. Biol. Chem. 281, 26976-26984
11. Mattioli, I., Geng, H., Sebald, A., Hodel, M., Bucher, C., Kracht, M., and Schmitz, M. L. (2006) Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J. Biol. Chem. 281, 6175-6183
12. Harris, J., Oliere, S., Sharma, S., Sun, Q., Lin, R., Hiscott, J., and Grandvaux, N. (2006) Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon. J. Immunol. 177, 2527-2535
13. Kim, J. M., Oh, Y. K., Lee, J. H., Im, D. Y., Kim, Y. J., Youn, J., Lee, C. H., Son, H., Lee, Y. S., Park, J. Y., and Choi, I. H. (2005) Induction of proinflammatory mediators requires activation of the TRAF, NIK, IKK and NF-kappaB signal transduction pathway in astrocytes infected with Escherichia coli. Clin. Exp. Immunol. 140, 450-460
14. Vollgraf, U., Wegner, M., and Richter-Landsberg, C. (1999) Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J. Neurochem. 73, 2501-2509
15. Lilienbaum, A., and Israel, A. (2003) From calcium to NF-kappa B signaling pathways in neurons. Mol. Cell. Biol. 23, 2680-2698
16. Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H., and Baeuerle, P. A. (1994) Constitutive NF-kappa B activity in neurons. Mol. Cell. Biol. 14, 3981-3992
17. Meffert, M. K., Chang, J. M., Wiltgen, B. J., Fanselow, M. S., and Baltimore, D. (2003) NF-kappa B functions in synaptic signaling and behavior. Nat. Neurosci. 6, 1072-1078
18. Paris, D., Patel, N., Quadros, A., Linan, M., Bakshi, P., Ait-Ghezala, G., and Mullan, M. (2007) Inhibition of Abeta production by NF-kappaB inhibitors. Neurosci. Lett. 415, 11-16
19. Maggirwar, S. B., Sarmiere, P. D., Dewhurst, S., and Freeman, R. S. (1998) Nerve growth factor-dependent activation of NF-kappaB contributes to survival of sympathetic neurons. J. Neurosci. 18, 10356-10365
20. Scholzke, M. N., Potrovita, I., Subramaniam, S., Prinz, S., and Schwaninger, M. (2003) Glutamate activates NF-kappaB through calpain in neurons. Eur. J. Neurosci. 18, 3305-3310
21. Grilli, M., and Memo, M. (1999) Possible role of NF-kappaB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ. 6, 22-27
22. Kaltschmidt, C., Kaltschmidt, B., and Baeuerle, P. A. (1993) Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech. Dev. 43, 135-147
23. Ehlers, M. D. (2003) Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat. Neurosci. 6, 231-242
24. Meffert, M. K., and Baltimore, D. (2005) Physiological functions for brain NF-kappaB. Trends Neurosci. 28, 37-43
25. Nickols, J. C., Valentine, W., Kanwal, S., and Carter, B. D. (2003) Activation of the transcription factor NF-kappaB in Schwann cells is required for peripheral myelin formation. Nat. Neurosci. 6, 161-167
26. Kassed, C. A., Willing, A. E., Garbuzova-Davis, S., Sanberg, P. R., and Pennypacker, K. R. (2002) Lack of NF-kappaB p50 exacerbates degeneration of hippocampal neurons after chemical exposure and impairs learning. Exp. Neurol. 176, 277-288
27. Kaltschmidt, B., Ndiaye, D., Korte, M., Pothion, S., Arbibe, L., Prullage, M., Pfeiffer, J., Lindecke, A., Staiger, V., Israel, A., Kaltschmidt, C., and Memet, S. (2006) NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol. Cell. Biol. 26, 2936-2946
28. Mattson, M. P., Goodman, Y., Luo, H., Fu, W., and Furukawa, K. (1997) Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681-697
29. Fernyhough, P., Smith, D. R., Schapansky, J., Van Der Ploeg, R., Gardiner, N. J., Tweed, C. W., Kontos, A., Freeman, L., Purves-Tyson, T. D., and Glazner, G. W. (2005) Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons. J. Neurosci. 25, 1682-1690
30. Nakai, M., Qin, Z. H., Chen, J. F., Wang, Y., and Chase, T. N. (2000) Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J. Neurochem. 74, 647-658
31. Mattson, M. P., and Meffert, M. K. (2006) Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 13, 852-860
32. Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B., and Kaltschmidt, C. (1999) Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. U. S. A. 96, 9409-9414
33. Niederberger, E., Tegeder, I., Vetter, G., Schmidtko, A., Schmidt, H., Euchenhofer, C., Brautigam, L., Grosch, S., and Geisslinger, G. (2001) Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. FASEB J. 15, 1622-1624
34. Mattson, M. P., and Camandola, S. (2001) NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247-254
35. Ma, W., and Bisby, M. A. (1998) Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res. 797, 243-254
36. Bethea, J. R., Castro, M., Keane, R. W., Lee, T. T., Dietrich, W. D., and Yezierski, R. P. (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18, 3251-3260
37. Podolin, P. L., Callahan, J. F., Bolognese, B. J., Li, Y. H., Carlson, K., Davis, T. G., Mellor, G. W., Evans, C., and Roshak, A. K. (2005) Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4- fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation. J. Pharmacol. Exp. Ther. 312, 373-381
38. McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Dambach, D. M., Pattoli, M. A., Lu, P., Zhou, X. D., Qiu, Y., Zusi, F. C., and Burke, J. R. (2003) A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum. 48, 2652-2659
39. Reuter, U., Chiarugi, A., Bolay, H., and Moskowitz, M. A. (2002) Nuclear factor-kappaB as a molecular target for migraine therapy. Ann. Neurol. 51, 507-516
40. Sarchielli, P., Floridi, A., Mancini, M. L., Rossi, C., Coppola, F., Baldi, A., Pini, L. A., and Calabresi, P. (2006) NF-kappaB activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia 26, 1071-1079
41. Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., Armstrong, A., Shen, V., Bain, S., Cosman, D., Anderson, D., Morrissey, P. J., Peschon, J. J., and Schuh, J. (1999) RANK is essential for osteoclast and lymph node development. Genes Dev. 13, 2412-2424
42. Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., and DePaoli, A. M. (2004) A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J. Bone Miner. Res. 19, 1059-1066
43. Pollock, G., Pennypacker, K. R., Memet, S., Israel, A., and Saporta, S. (2005) Activation of NF-kappaB in the mouse spinal cord following sciatic nerve transection. Exp. Brain Res. 165, 470-477
44. Niederberger, E., Schmidtko, A., Gao, W., Kuhlein, H., Ehnert, C., and Geisslinger, G. (2007) Impaired acute and inflammatory nociception in mice lacking the p50 subunit of NFkappaB. Eur. J. Pharmacol. 559, 55-60
45. Park, H. J., Lee, H. S., Lee, H. J., Yoo, Y. M., Kim, S. A., Leem, K., Kim, H. C., Seo, J. C., Kim, E. H., Lim, S., and Chung, J. H. (2002) Decrease of the electroacupuncture-induced analgesic effects in nuclear factor-kappa B1 knockout mice. Neurosci. Lett. 319, 141-144
46. Yin, M. J., Yamamoto, Y., and Gaynor, R. B. (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77-80
47. Geisslinger, G., Ferreira, S. H., Menzel, S., Schlott, D., and Brune, K. (1994) Antinociceptive actions of R(-)-flurbiprofen - a non-cyclooxygenase inhibiting 2-arylpropionic acid - in rats. Life Sci. 54, PL173-177
48. Malmberg, A. B., and Yaksh, T. L. (1994) Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test. Eur. J. Pharmacol. 256, 205-209
49. Tegeder, I., Niederberger, E., Israr, E., Guhring, H., Brune, K., Euchenhofer, C., Grosch, S., and Geisslinger, G. (2001) Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen. FASEB J. 15, 2-4
50. Niederberger, E., Tegeder, I., Schafer, C., Seegel, M., Grosch, S., and Geisslinger, G. (2003) Opposite effects of rofecoxib on nuclear factor-kappaB and activating protein-1 activation. J. Pharmacol. Exp. Ther. 304, 1153-1160
51. Niederberger, E., Manderscheid, C., and Geisslinger, G. (2006) Different COX-independent effects of the COX-2 inhibitors etoricoxib and lumiracoxib. Biochem. Biophys. Res. Commun. 342, 940-948
52. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M. (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286-290
53. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., and Baldwin, A. S., Jr. (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270, 283-286
54. Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., and Baldwin, A. S., Jr. (1995) Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15, 943-953
55. Zhang, R. X., Lao, L., Qiao, J. T., Malsnee, K., and Ruda, M. A. (2004) Endogenous and exogenous glucocorticoid suppresses up-regulation of preprodynorphin mRNA and hyperalgesia in rats with peripheral inflammation. Neurosci. Lett. 359, 85-88
56. Ma, Z. L., Zhang, W., Gu, X. P., Yang, W. S., and Zeng, Y. M. (2007) Effects of intrathecal injection of prednisolone acetate on expression of NR2B subunit and nNOS in spinal cord of rats after chronic compression of dorsal root ganglia. Ann. Clin. Lab. Sci. 37, 349-355
57. Li, H., Xie, W., Strong, J. A., and Zhang, J. M. (2007) Systemic antiinflammatory corticosteroid reduces mechanical pain behavior, sympathetic sprouting, and elevation of proinflammatory cytokines in a rat model of neuropathic pain. Anesthesiology 107, 469-477
58. Xie, W., Liu, X., Xuan, H., Luo, S., Zhao, X., Zhou, Z., and Xu, J. (2006) Effect of betamethasone on neuropathic pain and cerebral expression of NF-kappaB and cytokines. Neurosci. Lett. 393, 255-259
59. Wang, S., Lim, G., Zeng, Q., Sung, B., Ai, Y., Guo, G., Yang, L., and Mao, J. (2004) Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J. Neurosci. 24, 8595-8605
60. Takasaki, I., Kurihara, T., Saegusa, H., Zong, S., and Tanabe, T. (2005) Effects of glucocorticoid receptor antagonists on allodynia and hyperalgesia in mouse model of neuropathic pain. Eur. J. Pharmacol. 524, 80-83
61. Jin, S. H., Kim, T. I., Han, D. S., Shin, S. K., and Kim, W. H. (2002) Thalidomide suppresses the interleukin 1beta-induced NFkappaB signaling pathway in colon cancer cells. Ann. N. Y. Acad. Sci. 973, 414-418
62. Keifer, J. A., Guttridge, D. C., Ashburner, B. P., and Baldwin, A. S., Jr. (2001) Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity. J. Biol. Chem. 276, 22382-22387
63. Lv, P., Luo, H. S., Zhou, X. P., Xiao, Y. J., Paul, S. C., Si, X. M., and Zhou, Y. H. (2007) Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear factor-kappaB/inhibitor of nuclear factor-kappaB pathway. Arch. Med. Res. 38, 15-27
64. George, A., Marziniak, M., Schafers, M., Toyka, K. V., and Sommer, C. (2000) Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain 88, 267-275
65. Sommer, C., Marziniak, M., and Myers, R. R. (1998) The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve. Pain 74, 83-91
66. Ribeiro, R. A., Vale, M. L., Ferreira, S. H., and Cunha, F. Q. (2000) Analgesic effect of thalidomide on inflammatory pain. Eur. J. Pharmacol. 391, 97-103
67. Singh, A., Naidu, P. S., Patil, C. S., and Kulkarni, S. K. (2003) Effect of FK506 (tacrolimus) in animal models of inflammation. Inflammopharmacology 11, 249-257
68. Ohtori, S., Takahashi, K., Moriya, H., and Myers, R. R. (2004) TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine 29, 1082-1088
69. Xu, J. T., Xin, W. J., Zang, Y., Wu, C. Y., and Liu, X. G. (2006) The role of tumor necrosis factor-alpha in the neuropathic pain induced by Lumbar 5 ventral root transection in rat. Pain 123, 306-321
70. Sommer, C., Schafers, M., Marziniak, M., and Toyka, K. V. (2001) Etanercept reduces hyperalgesia in experimental painful neuropathy. J. Peripher. Nerv. Syst. 6, 67-72
71. Liu, Y. L., Zhou, L. J., Hu, N. W., Xu, J. T., Wu, C. Y., Zhang, T., Li, Y. Y., and Liu, X. G. (2007) Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology 52, 708-715
72. Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., and Moldawer, L. L. (2003) Anti-TNF-alpha therapies: the next generation. Nat. Rev. Drug Discov. 2, 736-746
73. Braddock, M., and Quinn, A. (2004) Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat. Rev. Drug Discov. 3, 330-339
74. Oka, T., Aou, S., and Hori, T. (1993) Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats. Brain Res. 624, 61-68
75. Watkins, L. R., Martin, D., Ulrich, P., Tracey, K. J., and Maier, S. F. (1997) Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71, 225-235
76. Davis, A. J., and Perkins, M. N. (1996) Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors. Br. J. Pharmacol. 118, 2206-2212
77. Laughlin, T. M., Bethea, J. R., Yezierski, R. P., and Wilcox, G. L. (2000) Cytokine involvement in dynorphin-induced allodynia. Pain 84, 159-167
78. Haslbeck, K. M., Neundorfer, B., Schlotzer-Schrehardtt, U., Bierhaus, A., Schleicher, E., Pauli, E., Haslbeck, M., Hecht, M., Nawroth, P., and Heuss, D. (2007) Activation of the RAGE pathway: a general mechanism in the pathogenesis of polyneuropathies? Neurol. Res. 29, 103-110
79. Bierhaus, A., Haslbeck, K. M., Humpert, P. M., Liliensiek, B., Dehmer, T., Morcos, M., Sayed, A. A., Andrassy, M., Schiekofer, S., Schneider, J. G., Schulz, J. B., Heuss, D., Neundorfer, B., Dierl, S., Huber, J., Tritschler, H., Schmidt, A. M., Schwaninger, M., Haering, H. U., Schleicher, E., Kasper, M., Stern, D. M., Arnold, B., and Nawroth, P. P. (2004) Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J. Clin. Invest. 114, 1741-1751
80. Steenvoorden, M. M., Huizinga, T. W., Verzijl, N., Bank, R. A., Ronday, H. K., Luning, H. A., Lafeber, F. P., Toes, R. E., and DeGroot, J. (2006) Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum. 54, 253-263
81. Sunahori, K., Yamamura, M., Yamana, J., Takasugi, K., Kawashima, M., and Makino, H. (2006) Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 54, 97-104
82. Hofmann, M. A., Drury, S., Hudson, B. I., Gleason, M. R., Qu, W., Lu, Y., Lalla, E., Chitnis, S., Monteiro, J., Stickland, M. H., Bucciarelli, L. G., Moser, B., Moxley, G., Itescu, S., Grant, P. J., Gregersen, P. K., Stern, D. M., and Schmidt, A. M. (2002) RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 3, 123-135
83. Tegeder, I., Niederberger, E., Schmidt, R., Kunz, S., Guhring, H., Ritzeler, O., Michaelis, M., and Geisslinger, G. (2004) Specific inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J. Neurosci. 24, 1637-1645
84. Ebersberger, A., Buchmann, M., Ritzeler, O., Michaelis, M., and Schaible, H. G. (2006) The role of spinal nuclear factor-kappa B in spinal hyperexcitability. NeuroReport 17, 1615-1618
85. Aupperle, K. R., Yamanishi, Y., Bennett, B. L., Mercurio, F., Boyle, D. L., and Firestein, G. S. (2001) Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell. Immunol. 214, 54-59
86. Sweeney, S. E., Hammaker, D., Boyle, D. L., and Firestein, G. S. (2005) Regulation of c-Jun phosphorylation by the I kappa B kinase-epsilon complex in fibroblast-like synoviocytes. J. Immunol. 174, 6424-6430
87. Perkins, N. D. (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell. Biol. 8, 49-62
88. Strickland, I., and Ghosh, S. (2006) Use of cell permeable NBD peptides for suppression of inflammation. Ann. Rheum. Dis. 65(Suppl. 3), iii75-iii82
89. Frelin, C., Imbert, V., Griessinger, E., Peyron, A. C., Rochet, N., Philip, P., Dageville, C., Sirvent, A., Hummelsberger, M., Berard, E., Dreano, M., Sirvent, N., and Peyron, J. F. (2005) Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells. Blood 105, 804-811
90. Tanaka, M., Fuentes, M. E., Yamaguchi, K., Durnin, M. H., Dalrymple, S. A., Hardy, K. L., and Goeddel, D. V. (1999) Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 10, 421-429
91. Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L. C., Goode, J., Miething, C., Goktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., Van Rooijen, N., Xu, Y., O'Cain, T., Jaffee, B. B., Busch, D. H., Duyster, J., Schmid, R. M., Eckmann, L., and Karin, M. (2007) NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130, 918-931
92. Di Meglio, P., Ianaro, A., and Ghosh, S. (2005) Amelioration of acute inflammation by systemic administration of a cell-permeable peptide inhibitor of NF-kappaB activation. Arthritis Rheum. 52, 951-958
93. Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., Okabe, K., Ohya, K., and Ghosh, S. (2004) Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat. Med. 10, 617-624
94. O'Neill, L. A. (2006) Targeting signal transduction as a strategy to treat inflammatory diseases. Nat. Rev. Drug Discov. 5, 549-563
95. Cavaletti, G., and Nobile-Orazio, E. (2007) Bortezomib-induced peripheral neurotoxicity: still far from a painless gain. Haematologica 92, 1308-1310
96. Schreck, R., Meier, B., Mannel, D. N., Droge, W., and Baeuerle, P. A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175, 1181-1194
97. Iseki, A., Kambe, F., Okumura, K., Niwata, S., Yamamoto, R., Hayakawa, T., and Seo, H. (2000) Pyrrolidine dithiocarbamate inhibits TNF-alpha-dependent activation of NF-kappaB by increasing intracellular copper level in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 276, 88-92
98. Hayakawa, M., Miyashita, H., Sakamoto, I., Kitagawa, M., Tanaka, H., Yasuda, H., Karin, M., and Kikugawa, K. (2003) Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J. 22, 3356-3366
99. Wei, X. H., Zang, Y., Wu, C. Y., Xu, J. T., Xin, W. J., and Liu, X. G. (2007) Peri-sciatic administration of recombinant rat TNF-alpha induces mechanical allodynia via upregulation of TNF-alpha in dorsal root ganglia and in spinal dorsal horn: the role of NF-kappa B pathway. Exp. Neurol. 205, 471-484
100. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghosh, S., and Karin, M. (1996) Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16, 1295-1304
101. Blackwell, N. M., Sembi, P., Newson, J. S., Lawrence, T., Gilroy, D. W., and Kabouridis, P. S. (2004) Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor. Arthritis Rheum. 50, 2675-2684
102. Meunier, A., Latremoliere, A., Dominguez, E., Mauborgne, A., Philippe, S., Hamon, M., Mallet, J., Benoliel, J. J., and Pohl, M. (2007) Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat. Mol. Ther. 15, 687-697
103. Fu, E. S., Zhang, Y. P., Sagen, J., Yang, Z. Q., and Bethea, J. R. (2007) Transgenic glial nuclear factor-kappa B inhibition decreases formalin pain in mice. NeuroReport 18, 713-717
104. Brambilla, R., Bracchi-Ricard, V., Hu, W. H., Frydel, B., Bramwell, A., Karmally, S., Green, E. J., and Bethea, J. R. (2005) Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202, 145-156
105. D'Acquisto, F., and Ianaro, A. (2006) From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors. Curr. Opin. Pharmacol. 6, 387-392
106. Ledeboer, A., Gamanos, M., Lai, W., Martin, D., Maier, S. F., Watkins, L. R., and Quan, N. (2005) Involvement of spinal cord nuclear factor kappaB activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur. J. Neurosci. 22, 1977-1986
107. Wu, F., and Chakravarti, S. (2007) Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kappaB inhibition in a mouse model of chronic colitis. J. Immunol. 179, 6988-7000
108. Lawrance, I. C., Wu, F., Leite, A. Z., Willis, J., West, G. A., Fiocchi, C., and Chakravarti, S. (2003) A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology 125, 1750-1761
109. Sun, T., Song, W. G., Fu, Z. J., Liu, Z. H., Liu, Y. M., and Yao, S. L. (2006) Alleviation of neuropathic pain by intrathecal injection of antisense oligonucleotides to p65 subunit of NF-kappaB. Br. J. Anaesth. 97, 553-558
110. Morishita, R., Tomita, N., Kaneda, Y., and Ogihara, T. (2004) Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. Curr. Opin. Pharmacol. 4, 139-146
111. Inoue, G., Ochiai, N., Ohtori, S., Nakagawa, K., Gemba, T., Doya, H., Ito, T., Koshi, T., Moriya, H., and Takahashi, K. (2006) Injection of nuclear factor-kappa B decoy into the sciatic nerve suppresses mechanical allodynia and thermal hyperalgesia in a rat inflammatory pain model. Spine 31, 2904-2908
112. Lee, K. M., Kang, B. S., Lee, H. L., Son, S. J., Hwang, S. H., Kim, D. S., Park, J. S., and Cho, H. J. (2004) Spinal NF-kB activation induces COX-2 upregulation and contributes to inflammatory pain hypersensitivity. Eur. J. Neurosci. 19, 3375-3381
113. Igwe, O. J. (2005) Modulation of peripheral inflammation in sensory ganglia by nuclear factor (kappa)B decoy oligodeoxynucleotide: involvement of SRC kinase pathway. Neurosci. Lett. 381, 114-119
114. D'Acquisto, F., Ialenti, A., Ianaro, A., Di Vaio, R., and Carnuccio, R. (2000) Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw. Gene Ther. 7, 1731-1737
115. Sakaue, G., Shimaoka, M., Fukuoka, T., Hiroi, T., Inoue, T., Hashimoto, N., Sakaguchi, T., Sawa, Y., Morishita, R., Kiyono, H., Noguchi, K., and Mashimo, T. (2001) NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. NeuroReport 12, 2079-2084
116. Tomita, T., Takano, H., Tomita, N., Morishita, R., Kaneko, M., Shi, K., Takahi, K., Nakase, T., Kaneda, Y., Yoshikawa, H., and Ochi, T. (2000) Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. Rheumatology (Oxford) 39, 749-757
117. Lianxu, C., Hongti, J., and Changlong, Y. (2006) NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. Osteoarthritis Cartilage 14, 367-376
118. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., and Baltimore, D. (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376, 167-170
119. Rudolph, D., Yeh, W. C., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A. J., and Mak, T. W. (2000) Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. Genes Dev. 14, 854-862
120. Li, Q., Lu, Q., Hwang, J. Y., Buscher, D., Lee, K. F., Izpisua-Belmonte, J. C., and Verma, I. M. (1999) IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13, 1322-1328